Equibles does not estimate personal net worth.
Get an email with a short summary when Precision Biosciences Inc publishes a filing, an earnings call transcript or a press release.
Get DTIL alertsCassie Gorsuch has spoken on 1 investor event across 1 company, most recently for Precision Biosciences Inc on April 14, 2026. Precision Biosciences Inc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Precision Biosciences Inc includes Matthew Kane (CEO), Naresh Tanna (CFO), Alex Kelly (COO and Chief Accounting Officer) and 7 others.
“I want to touch first on really the platform that Precision was built on, our Arcus gene editing technology. As Alex mentioned, we have a proprietary gene editing technology at Precision that our scientific founders, including Jeff Smith, developed.”
Transcript header (unverified)
Biotechnology · Healthcare
